The road to commercializing cell and gene therapies has been long, with many highs and lows along the way. However, the last few years have seen strong market growth and a very crowded pipeline. In this episode, ZS’s Jennifer Curtis and Sankalp Sethi discuss ongoing challenges and what it will take to successfully launch and commercialize these cutting-edge therapies in the U.S. and abroad.